Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LSD1 inhibits the invasion and migration of breast cancer through exosomes

ABSTRACT: LSD1 inhibits the invasion and migration of breast cancer through exosomes

PROVIDER: PRJNA1109273 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28962267_1.fastq.gz	Fastqsanger.gz
	SRR28962267_2.fastq.gz	Fastqsanger.gz
	SRR28962268_1.fastq.gz	Fastqsanger.gz
	SRR28962268_2.fastq.gz	Fastqsanger.gz
	SRR28962269_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

LSD1 inhibits the invasion and migration of breast cancer through exosomes

Project description:Metastasis accounts for almost 90% of breast cancer-related fatalities, making it frequent malignancy and the main reason of tumor mortality globally among women. A key player in breast cancer is the histone demethylase lysine-specific demethylase 1 (LSD1). We used LSD1 knockdown MCF7 and T47D cell exosomes to treat breast cancer cells for greatly increasing the invasion and migration of breast cancer cells for evaluating the impact of LSD1 on breast cancer invasion and migration. miR-1290 expression was downregulated in LSD1 knockdown MCF7 exosomes. Furthermore, miR-1290 could control NAT1 expression by looking through the database of miR-1290 target genes. These data provide fresh insights into the biology of breast cancer therapy by demonstrating how the epigenetic factor LSD1 stimulates the breast cancer cells’ invasion and migration via controlling exosomal miRNA.

2024-07-31 | GSE266982 | GEO

Cancer-associated E239K mutation of LSD1 promotes the migration and invasion of luminal breast cancer cells by reducing the expression of ERα

Project description:Background: Epithelial to mesenchymal transition (EMT) plays an essential role in the metastasis of breast cancer by regulating the migration and invasion of cancer cells. Lysine specific demethylase 1 (LSD1) is an important histone demethylase that mediates EMT. However, the functional effects of the mutation on LSD1 in breast cancer remain unclear. Results: An E239K mutation of LSD1 was identified from TCGA Breast Invasive Carcinoma cohort. To investigate the functional effects of the E239K mutation of LSD1, a stable LSD1 knockdown MCF7 cell line was generated. Rescue with the wild-type LSD1, but not the E239K mutated LSD1, suppressed the increased invasion of the LSD1 knockdown cells, demonstrating that the E239K mutation abolished the suppressive effects of LSD1 on the invasion of breast cancer cells. Further analysis showed that the E239K mutation of LSD1 led to decreased expression of estrogen receptor α (ERα), which subsequently increased the expression of Slug, a master transcription factor that promoted EMT. Most importantly, the E239K mutation of LSD1 disrupted the interaction between LSD1 and GATA3, which reduced the enrichment of LSD1 at the promoter region of ERα gene. The reduced enrichment of LSD1 at the promoter region of ERα gene caused enhanced histone H3K9 methylation, which in turn suppressed the transcription of ERα gene. Conclusions: The E239K mutation of LSD1 promotes the migration and invasion of breast cancer cells by disrupting the interaction between LSD1 and GATA3, which reduces the expression of ERα by enhancing the histone H3K9 methylation.

2021-03-12 | GSE168706 | GEO

LSD1 inhibits the invasion and migration of breast cancer through exosomes.

Project description:Metastasis accounts for almost 90% of breast cancer-related fatalities, making it frequent malignancy and the main reason of tumor mortality globally among women. LSD1 is a histone demethylase, which plays an important role in breast cancer. In order to explore the effect of LSD1 on invasion and migration of breast cancer, we treated breast cancer cells with MCF7 and T47D exosomes knocked down by LSD1, and the invasion and migration of breast cancer cells were significantly enhanced. This phenomenon indicates that LSD1 can inhibit the invasion and migration of breast cancer cells. miR-1290 expression was downregulated in LSD1 knockdown MCF7 exosomes. By analyzing the database of miR-1290 target gene NAT1, we verified that miR-1290 could regulate the expression of NAT1. These data provide fresh insights into the biology of breast cancer therapy by demonstrating how the epigenetic factor LSD1 stimulates the breast cancer cells' invasion and migration via controlling exosomal miRNA.

| S-EPMC11379686 | biostudies-literature

MIR193BHG inhibits the proliferation, migration and invasion of trophoblasts by upregulating p53

Project description:MIR193BHG inhibits the proliferation, migration and invasion of trophoblasts by upregulating p53

| PRJNA1027746 | ENA

Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration and invasion

Project description:Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration and invasion

| PRJNA784305 | ENA

Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration and invasion

Project description:Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration and invasion

| PRJNA784278 | ENA

TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy

Project description:TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy

| PRJNA990741 | ENA

YWHAB over-expression inhibits migration and invasion of breast cancer MDA-MB-231 cells

Project description:YWHAB over-expression inhibits migration and invasion of breast cancer MDA-MB-231 cells

| PRJNA903890 | ENA

TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy [RNA-seq]

Project description:TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy [RNA-seq]

| PRJNA990751 | ENA

TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy [MeDIP-Seq]

Project description:TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy [MeDIP-Seq]

| PRJNA989659 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data